Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 7/20 | 0.58 |
| ▸ | PRNP | P04156 | 1/20 | 0.52 |
| ▸ | PPARG | P37231 | 1/20 | 0.52 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.52 |
| ▸ | METAP1 | P53582 | 4/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 3/20 | 0.43 |
| ▸ | HTR2C | P28335 | 3/20 | 0.43 |
| ▸ | HTR2B | P41595 | 3/20 | 0.43 |
| ▸ | DRD2 | P14416 | 2/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4611650 | 1.00 | ACHE (0.58) | ACHEPRNPPPARGNCOR2METAP1 | |
| SCHEMBL11770519 | 0.85 | ACHE (0.55) | ACHEPRNPPPARGNCOR2METAP1 | |
| SCHEMBL10346131 | 0.81 | KDM4E (0.55) | ACHEHTR2AHTR2CHTR2BDRD2 | |
| SCHEMBL14447190 | 0.81 | ACHE (0.50) | ACHEPRNPPPARGNCOR2METAP1 | |
| SCHEMBL20207026 | 0.81 | S100A4 (0.53) | ACHEPRNPPPARGNCOR2HTR2B | |
| SCHEMBL12237089 | 0.79 | ACHE (0.47) | ACHEPRNPPPARGNCOR2METAP1 | |
| SCHEMBL5952596 | 0.79 | HTR1A (0.46) | ACHEPRNPPPARGNCOR2HTR2A | |
| SCHEMBL28461412 | 0.78 | ACHE (0.50) | ACHEPRNPPPARGNCOR2METAP1 | |
| SCHEMBL21294251 | 0.77 | ACHE (0.62) | ACHEPRNPPPARGNCOR2METAP1 | |
| SCHEMBL10752402 | 0.77 | ACHE (0.49) | ACHEMETAP1SIGMAR1CYP19A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190276469-A1 | Cyclic Ketals As Fragrance Precursor Compounds | HENKEL AG & CO. KGAA (DE) | 2019-09-12 | — | — | US | claimed |
| EP-3523414-A1 | CYCLIC KETALS AS FRAGRANCE PRECURSOR COMPOUNDS | Henkel AG & Co. KGaA (DE) | 2019-08-14 | — | — | EP | claimed |
| US-20190010293-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| WO-2018095814-A1 | CYCLIC KETALS AS FRAGRANCE PRECURSOR COMPOUNDS | HENKEL AG & CO. KGAA (DE) | 2018-05-31 | — | — | WO | claimed |
| US-20220009153-A1 | COMPOSITION FOR FORMING PATTERN, KIT, CURED FILM, LAMINATE, PATTERN PRODUCING METHOD, AND METHOD FOR MANUFACTURING SEMICONDUCTOR ELEMENT | FUJIFILM CORPORATION (JP) | 2022-01-13 | — | — | US | disclosed |
| US-10941156-B2 | Cyclic ketals as fragrance precursor compounds | HENKEL AG & CO. KGAA (DE) | 2021-03-09 | — | — | US | disclosed |
| CN-110204468-B | Asymmetric synthesis method of chiral alpha-thiocyano cyclic ketonic acid ester compound | 浙江工业大学 | 2021-02-02 | — | — | CN | disclosed |
| US-20190276469-A1 | Cyclic Ketals As Fragrance Precursor Compounds | HENKEL AG & CO. KGAA (DE) | 2019-09-12 | — | — | US | disclosed |
| EP-3523414-A1 | CYCLIC KETALS AS FRAGRANCE PRECURSOR COMPOUNDS | Henkel AG & Co. KGaA (DE) | 2019-08-14 | — | — | EP | disclosed |
| US-20190010293-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | disclosed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | disclosed |
| CN-1471570-A | Fabric care compositions containing cationic polysiloxanes and methods of use thereof | — | 2004-01-28 | — | — | CN | disclosed |
| US-6492563-B2 | PROVIDES NON-VOLATILE PRECURSORS FOR VOLATILE FRAGRANT ESTERS FOR USE IN DETERGENT, A FABRIC SOFTENER, A WINDOW CLEANER, A HARD SURFACE CLEANER, AN ALL PURPOSE CLEANER, A FURNITURE POLISH, A SHAMPOO, A CONDITIONER, AN HAIRSPRAY, A COSMETIC | GIVAUDAN SA (CH) | 2002-12-10 | — | — | US | disclosed |
| US-20020077508-A1 | Fragrance precursors | GIVAUDAN SA (CH) | 2002-06-20 | — | — | US | disclosed |
| US-20020035055-A1 | Fragrance precursors | GIVAUDAN SA (CH) | 2002-03-21 | — | — | US | disclosed |
| EP-1167362-A1 | Fragance precursors | Givaudan SA (CH) | 2002-01-02 | — | — | EP | disclosed |
| EP-1146033-A2 | Fragrance precursors | Givaudan SA (CH) | 2001-10-17 | — | — | EP | disclosed |
| US-6258854-B1 | KETONE ETHERS FOR ODORS | GIVAUDAN ROURE ( INTERNATIONAL ) SA (CH) | 2001-07-10 | — | — | US | disclosed |
| EP-0983990-A2 | Ketones useful as precursors for organoleptic compounds | Givaudan Roure (International) S.A. (CH) | 2000-03-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10941156-B2 | Cyclic ketals as fragrance precursor compounds | KCNK5, KLK5, KCNA1 | ACHE 300/4885PRNP 3370/4885PPARG 4039/4885 |
| US-20020077508-A1 | Fragrance precursors | ADH5, FAAH, CBR3 | ACHE 3921/4885PRNP 4469/4885PPARG 2743/4885 |
| US-20190276469-A1 | Cyclic Ketals As Fragrance Precursor Compounds | KCNK5, KLK5, KCNA1 | ACHE 300/4885PRNP 3370/4885PPARG 4039/4885 |
| US-20020035055-A1 | Fragrance precursors | FAAH2, FDPS, CYP51A1 | ACHE 1455/4885PRNP 4712/4885PPARG 1670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.